83 related articles for article (PubMed ID: 23195074)
1. Herbal medicines in migraine prevention Randomized double-blind placebo-controlled crossover trial of a feverfew preparation.
De Weerdt CJ; Bootsma HP; Hendriks H
Phytomedicine; 1996 Nov; 3(3):225-30. PubMed ID: 23195074
[TBL] [Abstract][Full Text] [Related]
2. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
3. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
Murphy JJ; Heptinstall S; Mitchell JR
Lancet; 1988 Jul; 2(8604):189-92. PubMed ID: 2899663
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
[TBL] [Abstract][Full Text] [Related]
5. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Maizels M; Blumenfeld A; Burchette R
Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of feverfew as prophylactic treatment of migraine.
Johnson ES; Kadam NP; Hylands DM; Hylands PJ
Br Med J (Clin Res Ed); 1985 Aug; 291(6495):569-73. PubMed ID: 3929876
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
13. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
Grossman W; Schmidramsl H
Altern Med Rev; 2001 Jun; 6(3):303-10. PubMed ID: 11410074
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S
Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.
Slater SK; Nelson TD; Kabbouche MA; LeCates SL; Horn P; Segers A; Manning P; Powers SW; Hershey AD
Cephalalgia; 2011 Jun; 31(8):897-905. PubMed ID: 21586650
[TBL] [Abstract][Full Text] [Related]
17. Feverfew for preventing migraine.
Pittler MH; Vogler BK; Ernst E
Cochrane Database Syst Rev; 2000; (3):CD002286. PubMed ID: 10908545
[TBL] [Abstract][Full Text] [Related]
18. Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
Charles JA; Jotkowitz S; Byrd LH
Headache; 2006 Mar; 46(3):503-7. PubMed ID: 16618270
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.
Ernst E; Pittler MH
Public Health Nutr; 2000 Dec; 3(4A):509-14. PubMed ID: 11276299
[TBL] [Abstract][Full Text] [Related]
20. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomized, crossover, double blind, placebo-controlled, clinical study.
Vécsei L; Gallacchi G; Sági I; Semjén J; Tajti J; Szok D; Müller M; Vadass P; Kerékgyártó M
Cephalalgia; 2007 Jan; 27(1):29-34. PubMed ID: 17212680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
